SGLT2 Deletion Improves Glucose Homeostasis and Preserves Pancreatic β-Cell Function

Abstract

OBJECTIVEInhibition of the Na+-glucose cotransporter type 2 (SGLT2) is currently being pursued as an insulin-independent treatment for diabetes; however, the behavioral and metabolic consequences of SGLT2 deletion are unknown. Here, we used a SGLT2 knockout mouse to investigate the effect of increased renal glucose excretion on glucose homeostasis, insulin sensitivity, and pancreatic β-cell function.RESEARCH DESIGN AND METHODSSGLT2 knockout mice were fed regular chow or a high-fat diet (HFD) for 4 weeks, or backcrossed onto the db/db background. The analysis used metabolic cages, glucose tolerance tests, euglycemic and hyperglycemic clamps, as well as isolated islet and perifusion studies.RESULTSSGLT2 deletion resulted in a threefold increase in urine output and a 500-fold increase in glucosuria, as well as compensatory increases in feeding, drinking, and activity. SGLT2 knockout mice were protected from HFD-induced hyperglycemia and glucose intolerance and had reduced plasma insulin concentrations compared with controls. On the db/db background, SGLT2 deletion prevented fasting hyperglycemia, and plasma insulin levels were also dramatically improved. Strikingly, prevention of hyperglycemia by SGLT2 knockout in db/db mice preserved pancreatic β-cell function in vivo, which was associated with a 60% increase in β-cell mass and reduced incidence of β-cell death.CONCLUSIONSPrevention of renal glucose reabsorption by SGLT2 deletion reduced HFD- and obesity-associated hyperglycemia, improved glucose intolerance, and increased glucose-stimulated insulin secretion in vivo. Taken together, these data support SGLT2 inhibition as a viable insulin-independent treatment of type 2 diabetes.

Hypothalamic prolyl endopeptidase (PREP) regulates pancreatic insulin and glucagon secretion in mice

“…Isolated islet studies were conducted as previously described (31). Islets were loaded into a perifusion chamber with acrylamide gel column beads (Bio-Gel P4G; Bio-Rad) and basal perfusion buffer (Krebs-Ringer buffer with 2.5 mmol/L glucose and 0.2% fatty acid-free BSA).…”

Saturated and unsaturated fat induce hepatic insulin resistance independently of TLR-4 signaling and ceramide synthesis in vivo

“…Hepatic triglycerides were extracted using a methanol/chloroform-based method (4) and quantified with a colorimetric kit (Genzyme); diacylglycerols and ceramide levels were measured as previously described (4,43).…”

The Non-glycemic Effects of SGLT2 Inhibitor

“…제2형 당뇨병 환자에서 canagliflozin 투여 시 HDL-콜레스테롤 농도를 유의하게 증가시키고 LDL-콜레스테롤 농도를 증가시키며 대상자에 따라서 중성지 방 농도를 감소시킨다는 보고도 있다 [22,33]. 그러나 CKD 3기 환자에서 canagliflozin 52주 투여 임상연구 에서는 오히려 LDL 콜레스테롤 농도가 대조군에 비해 서 낮고, HDL 콜레스테롤은 높은 경향을 보였다 [18].…”